Medical Equipment

Lung Cancer Surgery Equipment Global Forecast: Market to Scale Up to $5.09 Billion by 2030 at 6.4% CAGR

February 6, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

How much is the Lung Cancer Surgery Equipment Market valued at in 2026, and what valuation is forecast for 2030?

The lung cancer surgery equipment market has experienced strong growth in recent years. It is projected to increase from $3.73 billion in 2025 to $3.98 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. The growth observed in the historic period can be attributed to factors such as the limited availability of advanced thoracic surgery equipment, a reliance on traditional open surgeries, the increasing prevalence of lung cancer, a rising number of hospitals and surgical clinics, and the adoption of standard biopsy and imaging procedures.

The lung cancer surgery equipment market is anticipated to experience robust expansion over the coming years. This market is projected to reach $5.1 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. Key factors driving this growth during the forecast period include advancements in robotic-assisted and minimally invasive surgical instruments, the incorporation of AI-enabled imaging and monitoring solutions, increased funding in research and academic institutions, a greater embrace of enhanced recovery after surgery (ERAS) protocols, and the proliferation of specialized centers for lung cancer treatment. Significant trends anticipated in this period encompass a rise in minimally invasive lung surgical procedures, a heightened need for sophisticated imaging and diagnostic gear, the merging of patient monitoring systems with surgical apparatus, an increased emphasis on rehabilitation and aftercare post-surgery, and the broadened use of robotic-assisted thoracic surgery.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24594&type=smp

What Drivers Are Influencing The Growth Of The Lung Cancer Surgery Equipment Market?

The increasing incidence of lung cancer is projected to drive the expansion of the lung cancer surgery equipment market moving forward. This condition involves the unchecked proliferation of abnormal cells within the lungs, frequently attributed to factors like smoking or detrimental environmental exposure. The rise in lung cancer diagnoses is largely due to increased exposure to risk factors such as tobacco smoke, air pollution, and occupational carcinogens, alongside a demographic shift towards an aging population. Lung cancer surgery equipment plays a crucial role in diagnosis, the excision of cancerous tissue, and aiding post-operative recovery through precise surgical procedures and patient surveillance. For example, in February 2025, data from the Cancer Council, an Australia-based non-profit organization, indicated that in 2024, approximately 15,122 individuals in Australia were diagnosed with lung cancer, with the mean age at diagnosis reported as 72. In Australia, lung cancer is the fifth most commonly diagnosed cancer, and it is anticipated that around one in 20 Australians will receive this diagnosis by the age of 85. Consequently, the rising prevalence of lung cancer is fueling the growth of the lung cancer surgery equipment market.

How Is The Lung Cancer Surgery Equipment Market Organized Into Various Segments?

The lung cancer surgery equipment market covered in this report is segmented –

1) By Product Type: Surgical Instruments, Access Devices, Imaging Equipment, Electrosurgical Devices, Biopsy Devices, Patient Monitoring Equipment

2) By Surgery Type: Lobectomy Surgery, Pneumonectomy Surgery, Wedge Resection, Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

3) By Application: Diagnosis, Treatment, Aftercare And Rehabilitation

4) By End User: Hospitals, Surgical Clinics, Ambulatory Surgical Centers, Research And Academic Institutes

Subsegments:

1) By Surgical Instruments: Scalpels, Forceps, Retractors, Scissors, Sutures

2) By Access Devices: Trocars, Catheters, Guidewires, Introducers

3) By Imaging Equipment: CT Scanners, MRI Machines, PET Scanners, X-Ray Systems, Ultrasound Devices

4) By Electrosurgical Devices: Electrosurgical Generators, Electrosurgical Probes, Electrosurgical Electrodes, Smoke Evacuation Systems

5) By Biopsy Devices: Needle Biopsy Devices, Core Biopsy Devices, Vacuum-Assisted Biopsy Devices, Endoscopic Biopsy Devices

6) By Patient Monitoring Equipment: Pulse Oximeters, ECG Monitors, Respiratory Monitors, Blood Pressure Monitors, Temperature Monitors

How Are New Market Trends Shaping The Landscape Of The Lung Cancer Surgery Equipment Market?

Major entities operating in the lung cancer surgery equipment market are concentrating on developing devices for robotically assisted bronchoscopy. This focus aims to boost the precision and safety of tumor localization and biopsy, improve access to difficult-to-reach lung nodules, and support the early and accurate diagnosis of lung cancer. Robotically assisted bronchoscopy is an advanced medical procedure that utilizes robotic technology to guide a bronchoscope, a thin, flexible tube, into the lungs with greater precision and control than traditional manual techniques. For instance, in March 2025, Johnson and Johnson, a US-based pharmaceutical company, revealed that its MONARCH QUEST system, an advanced robotic-assisted bronchoscopy technology, had received U.S. FDA 510(k) clearance. This system marks the latest evolution of the MONARCH Platform, which is designed to enhance the diagnosis of lung cancer through minimally invasive procedures. The system also interfaces with the GE HealthCare OEC 3D mobile CBCT Imaging System, providing real-time, intraprocedural 3D imaging. This integration significantly improves the precision in targeting lung nodules, especially those found in hard-to-reach areas of the lung.

Who Are The Primary Competitors In The Global Lung Cancer Surgery Equipment Market?

Major companies operating in the lung cancer surgery equipment market are Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, KARL STORZ GmbH & Co KG, Integra LifeSciences Corporation, Richard Wolf GmbH, Angiodynamics Inc, B Braun Melsungen AG, Sontec Instruments Inc, Novadaq Technologies Inc, Stryker Corporation, CONMED Corporation, Smith & Nephew plc, Ambu A S

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

Which Regions Are Poised For Strategic Growth In The Lung Cancer Surgery Equipment Market?

North America was the largest region in the lung cancer surgery equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Lung Cancer Surgery Equipment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24594&type=smp

Browse Through More Reports Similar to the Global Lung Cancer Surgery Equipment Market 2026, By The Business Research Company

Lung Cancer Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Thoracic Surgery Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/thoracic-surgery-devices-global-market-report

Surgical Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/surgical-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795